What is the use of Imitrex (Sumatriptan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Imitrex (sumatriptan) is the most effective treatment for acute migraine headaches, with a high efficacy rating of 4, and should be used as the first-line treatment for patients with moderate to severe migraines or mild to moderate migraines that are unresponsive to analgesics or NSAIDs 1. The typical adult dose of Imitrex is 25-100mg orally at the onset of migraine symptoms, with a maximum daily dose of 200mg, and it is also available as a nasal spray (5-20mg per nostril) or injection (6mg subcutaneously) for faster relief 1. Key points to consider when prescribing Imitrex include:

  • Contraindications: heart disease, uncontrolled high blood pressure, use within 24 hours of other triptans or ergot medications, hemiplegic or basilar migraine, pregnancy, impaired hepatic function, and as prophylactic therapy 1
  • Common side effects: nausea, warmth, vomiting, vertigo, malaise, headache, injection site reactions, and chest pressure and heaviness 1
  • Potential interactions: SSRIs, MAOIs, and other triptans, which may increase the risk of serotonin syndrome 1 It is essential to consult the current Physician’s Desk Reference and other pharmacologic resources before prescribing Imitrex, as the information provided is not all-inclusive in treatment protocols, contraindications, or adverse reactions 1.

From the FDA Drug Label

Sumatriptan tablets, USP are a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. Not indicated for the prophylactic therapy of migraine attacks Not indicated for the treatment of cluster headache.

The primary use of Imitrex (sumatriptan) is for the acute treatment of migraine with or without aura in adults.

  • It is not indicated for the prophylactic therapy of migraine attacks.
  • It is not indicated for the treatment of cluster headache. 2

From the Research

Imitrex Overview

  • Imitrex, also known as sumatriptan, is a medication used to treat migraine headaches 3
  • It belongs to a class of drugs called triptans, which work by constricting blood vessels and blocking pain pathways in the brain 4

Efficacy of Imitrex

  • Studies have shown that Imitrex is effective in relieving migraine headache symptoms, with a therapeutic gain of 32% compared to placebo 3
  • Imitrex has been compared to other triptans, such as rizatriptan, and has been found to have similar efficacy 5, 6
  • However, some studies have suggested that newer triptans, such as rizatriptan, may have a faster onset of action and fewer adverse events than Imitrex 5, 6

Comparison to Other Migraine Treatments

  • Imitrex has been compared to other migraine treatments, including lasmiditan, rimegepant, and ubrogepant, and has been found to have higher odds ratios for pain freedom and pain relief at 2 hours 7
  • However, these newer treatments may have fewer cardiovascular risks and may be a viable alternative to triptans like Imitrex 7

Adverse Events

  • Imitrex has been associated with adverse events, including dizziness, drowsiness, and nausea 3, 5
  • The risk of adverse events with Imitrex is similar to that of other triptans, but may be higher than that of newer migraine treatments like lasmiditan, rimegepant, and ubrogepant 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.